ALPINE IMMUNE SCIENCES, INC. Lessee, Operating Lease, Liability, to be Paid, Year Three
ALPINE IMMUNE SCIENCES, INC. had Lessee, Operating Lease, Liability, to be Paid, Year Three of $2.22 million as of 2023-12-31, per its 10-K filed 2024-03-20.
Discontinued › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree · last filed 2024-03-20
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Three $2.22M.
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Three $2.17M.
- 2021-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Three $2.11M.
- 2020-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Three $2.06M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year Three |
|---|---|
| 2023-12-31 | $2.22M 10-K · filed 2024-03-20 |
| 2022-12-31 | $2.17M 10-K · filed 2023-03-23 |
| 2021-12-31 | $2.11M 10-K · filed 2022-03-17 |
| 2020-12-31 | $2.06M 10-K · filed 2021-03-18 |
| 2019-12-31 | $2.01M 10-K · filed 2020-03-30 |
| 2019-09-30 | $1.96M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $1.98M 10-Q · filed 2019-08-13 |